Illustrative catalog image. Refer to supplied product documentation for actual labeling.

OCN-TESA-05

Tesamorelin

N-terminally modified human GHRH(1–44) analogue

Peptide research material

Labeled quantity · 5 mg

$45.00

Submitted COA available

Research-use boundary

For laboratory research only. Not for human or veterinary use.

Ask about availability

Batch documentation

Certificate of Analysis

Review the submitted testing document and the results reported for this identified sample or batch.

Laboratory named on reportVeriChem Global Labs

Report referenceVCGL260321946NEM

Test / report dateSeptember 5, 2026

Approval date shownSeptember 15, 2026

Reported purity99.713% HPLC

Reported quantity5.28 mg sample amount

Original submitted document

PDF · 3 pages

View or download COA

The complete document is provided so customers can review the reported methods and results directly.

Important: This is a submitted batch document. The testing laboratory, chain of custody, sample source, report authenticity, and applicability to current inventory have not been independently verified by Oceantide Labs. A COA does not establish safety, sterility, regulatory approval, or suitability for human use.

Overview

What it is

Tesamorelin is a synthetic 44-residue analogue of human growth hormone-releasing hormone (GHRH), also called growth hormone-releasing factor (GRF). Its reference structure retains the full GHRH(1–44) peptide backbone.

A trans-3-hexenoyl group modifies the N-terminal tyrosine, and the reference peptide has a C-terminal amide. The chemical descriptor trans-3-hexenoyl-hGRF(1–44)-NH2 captures these terminal features. The cited chemistry review describes tesamorelin acetate; it does not confirm the salt form of this catalog material.

Documentation

Catalog notes

Tesamorelin’s N-terminal modification distinguishes its reference structure from unmodified GHRH.

The 5 mg label is the catalog quantity. The linked COA contains the current submitted sample results.

Reference

Product specifications

Scientific details describe reference chemistry, not batch-specific measurements. Consult the applicable supplied-material documentation for test results.

CompoundTesamorelin

Reference material classSynthetic GHRH / GRF peptide analogue

Reference chain length44 amino acid residues

Reference backboneHuman GHRH(1–44)

N-terminal modificationtrans-3-Hexenoyl group

C-terminal featureAmide (–NH2)

Labeled quantity5 mg

Price$45.00

Catalog referenceOCN-TESA-05

Scientific references

Source documents

Sources support the scientific descriptions above. They do not certify the identity, composition, or quality of the material supplied by Oceantide Labs.

FDA · Tesamorelin chemistry review (2010)Reference chemistry · does not certify this catalog material